{"schema_version":"secwatch.filing_event.v1","accession":"0001035267-24-000133","form_type":"8-K","ticker":"ISRG","cik":"0001035267","company_name":"INTUITIVE SURGICAL INC","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.960116+00:00","generated_at":"2026-06-03T17:54:23.846839+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Intuitive Q1 revenue $1.89B (+11% YoY), GAAP EPS $1.51, da Vinci procedures +16%","bullets":["Q1 revenue $1.89B (+11% YoY); GAAP EPS $1.51, non-GAAP EPS $1.50; procedure volume +16%.","Placed 313 da Vinci systems (8 da Vinci 5, 8 SP in Europe); installed base 8,887 (+14% YoY).","CE mark for da Vinci SP in Europe; FDA clearance for da Vinci 5; NMPA clearance for Ion in China.","Instruments & accessories revenue $1.16B (+18%); systems revenue $418M (slight decline).","Cash $7.32B; no COVID-19 procedure disruptions in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0001035267-24-000133","json":"https://secwatch.observer/filing/0001035267-24-000133.json","markdown":"https://secwatch.observer/filing/0001035267-24-000133.md","text":"https://secwatch.observer/filing/0001035267-24-000133.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035267/000103526724000133/0001035267-24-000133-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035267/000103526724000133/isrg-20240418.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T17:54:23.846839+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b0df7f4328df729cbd33d8c365178daa3c0c251","claim":"INTUITIVE SURGICAL INC reported the quarter ended March 31, 2024 results: revenue $1.89 billion, net income $545 million, EPS $1.51 per diluted share.","evidence_excerpt":"First quarter 2024 revenue of $1.89 billion increased 11% compared with $1.70 billion in the first quarter of 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526724000133/0001035267-24-000133-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"$1.89 billion"},{"label":"Net income","value":"$545 million"},{"label":"EPS","value":"$1.51 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}